Form 4: Waystar Holding Corp. Director Robert DeMichiei Receives Equity Grant

Waystar Holding Corp. Director Robert DeMichiei was granted 5,134 restricted stock units, increasing his beneficial ownership to 36,896 shares.

Summary

• Robert DeMichiei, a Director of Waystar Holding Corp. (WAY), acquired 5,134 shares of common stock on June 16, 2025.
• This acquisition was a grant of restricted stock units (RSUs) at a price of $0 per share, indicating it is a form of compensation.
• Each RSU represents a contingent right to receive one share of Common Stock upon settlement.
• The granted RSUs are scheduled to vest on the earlier of June 4, 2026, or the first regularly scheduled annual meeting of the stockholders following the grant date.
• Following this transaction, Mr. DeMichiei's total beneficial ownership in Waystar Holding Corp. stands at 36,896 shares, which includes unvested RSUs.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is a positive sign of alignment between management and shareholders, indicating continued commitment and incentivization. It's a routine, expected event for compensation.

Positives

• The grant of restricted stock units to a director aligns management's long-term interests with those of the shareholders.
• Increased beneficial ownership by a director demonstrates continued commitment and confidence in the company's future.

Future Outlook

The vesting schedule for the granted restricted stock units indicates future equity compensation will convert to common stock, aligning director incentives with long-term company performance and shareholder value creation.

Management Comments

• The filing was signed by Gregory R. Packer, as Attorney-in-Fact for Robert DeMichiei, indicating the use of a Power of Attorney for SEC filings.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity grant, which is a common practice in publicly traded companies across various industries to compensate and incentivize directors and executives, aligning their interests with the company's long-term success.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) as part of director compensation is a standard practice across various industries, including healthcare technology, aligning director interests with shareholder value creation.
• While specific comparable companies are not mentioned in the filing, similar equity compensation structures are observed at peers in the healthcare IT space, such as Veeva Systems (VEEV), Cerner (now Oracle Health), and Change Healthcare (now Optum Insight).

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with the company's stock performance, potentially encouraging decisions that enhance shareholder value.

Next Steps

• The granted restricted stock units will vest on the earlier of June 4, 2026, or the first regularly scheduled annual meeting of stockholders following the grant date, at which point they will convert into common stock.

Key Dates

Recommendation

Keywords

Waystar Holding Corp., WAY, Robert DeMichiei, Form 4, SEC filing, restricted stock units, RSUs, insider transaction, director compensation, equity grant, beneficial ownership